The NOLC1 antibody has been employed in diverse studies, with a focus on ribosome biogenesis, cancer biology, and genome editing:
NOLC1 is critical for nucleolar function, guiding site-specific 2'-O-methylation and pseudouridylation of pre-rRNAs . Overexpression disrupts rRNA processing, as shown by studies using this antibody to detect mislocalized nucleolar proteins .
Breast Cancer: High NOLC1 expression correlates with poor prognosis in triple-negative breast cancer (TNBC), as demonstrated by immunohistochemical analysis .
Nasopharyngeal Carcinoma: The antibody revealed that NOLC1 overexpression enhances tumorigenesis by activating MDM2 via TP53 .
In a study on CRISPR-directed integrases, the antibody confirmed NOLC1’s interaction with β-arrestin and fibrillarin, highlighting its role in rRNA biogenesis during colorectal tumorigenesis .
Protocols for Western blotting, IHC, and IF/ICC are available from the manufacturer. Key considerations include:
WB: Use 1:500–1:1000 dilution in TBST with 5% skim milk.
IHC: Optimize antigen retrieval with citrate buffer (pH 6.0) for paraffin sections .
The antibody has been cited in studies on: